Back
First Trust Nasdaq Cybersecurity ETF Vs. Corbus Pharmaceuticals Holdings, Inc. Industry Stock Comparison
Buy
53
CIBR
First Trust Nasdaq Cybersecurity ETF
Last Price:
$72.35
Seasonality Move:
2.81%
Sell
30
CRBP
Corbus Pharmaceuticals Holdings, Inc.
Last Price:
$8.04
Seasonality Move:
58.11%
Buy
53
First Trust Nasdaq Cybersecurity ETF (CIBR)
is a Buy
Is First Trust Nasdaq Cybersecurity ETF a Buy, Sell or Hold?
-
The current First Trust Nasdaq Cybersecurity ETF [CIBR] share price is $72.55. The Score for CIBR is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
CIBR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
is a Sell
Is Corbus Pharmaceuticals Holdings, Inc. a Buy, Sell or Hold?
-
The current Corbus Pharmaceuticals Holdings, Inc. [CRBP] share price is $8.23. The Score for CRBP is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
CRBP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CIBR Stock Price Chart
What is First Trust Nasdaq Cybersecurity ETF's stock price today?
-
The First Trust Nasdaq Cybersecurity ETF share price today is $72.55Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CIBR is experiencing slight selling pressure.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings, Inc.'s stock price today?
-
The Corbus Pharmaceuticals Holdings, Inc. share price today is $8.23Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRBP is experiencing slight buying pressure.
CIBR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.5 | Sell |
| Relative Strength Index (14 RSI): | 43.4 | Sell |
| Chaikin Money Flow: | -208235 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (72.13 - 74.75) | Sell |
| Bollinger Bands (100): | (72.59 - 76.53) | Sell |
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.98 | Sell |
| Relative Strength Index (14 RSI): | 30.12 | Sell |
| Chaikin Money Flow: | 70719 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.64 - 11.24) | Sell |
| Bollinger Bands (100): | (8.73 - 14.49) | Sell |
CIBR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.66 | Sell |
| 20-day SMA: | 73.7 | Sell |
| 50-day SMA: | 74.69 | Sell |
| 200-day SMA: | 72.01 | Buy |
| 8-day EMA: | 72.99 | Sell |
| 20-day EMA: | 73.47 | Sell |
| 50-day EMA: | 74.17 | Sell |
| 200-day EMA: | 71.93 | Buy |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.3 | Sell |
| 20-day SMA: | 9.51 | Sell |
| 50-day SMA: | 12.02 | Sell |
| 200-day SMA: | 9.52 | Sell |
| 8-day EMA: | 8.52 | Sell |
| 20-day EMA: | 9.4 | Sell |
| 50-day EMA: | 10.64 | Sell |
| 200-day EMA: | 7.51 | Buy |
First Trust Nasdaq Cybersecurity ETF Earnings Growth & CIBR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corbus Pharmaceuticals Holdings, Inc. Earnings Growth & CRBP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.34 per share, and an increase next year of $1.49 per share.
First Trust Nasdaq Cybersecurity ETF Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corbus Pharmaceuticals Holdings, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||